Top Abstract Purchase Related
Home
>
Node
>
Subnode

Atrial fibrillation as Risk Factor for Development of Cognitive Function Impairment and Dementia. Potential of Anticoagulant Therapy in Their Prevention

Ostroumova, O.D.; Cherniaeva, M.S.; Golovina, O.V.

Kardiologiia 58(9): 76-88

2018

ISSN/ISBN: 0022-9040
PMID: 30295203
Document Number: 696018
This article presents an overview of data of Russian and foreign literature on possible associations between cognitive impairment and atrial fibrillation (AF). It includes modern classification of cognitive impairment, mechanisms of the effect of AF on cognitive functions and development of dementia, recommendations for the prevention of cognitive impairment in patients with AF. Special attention is paid to the assessment of cognitive status, and safe anticoagulant therapy, which is a priority in the prevention of cognitive impairment in patients with AF. Analysis of literature showed greater efficacy and safety of drugs from the group of Non-vitamin K Antagonist Oral Anticoagulants (NOAC), rivaroxaban in particular, in comparison with warfarin. Drugs from the NOAC group can be recommended for prevention stroke, cognitive impairment and dementia in elderly patients with AF.

Document emailed within 1 workday
Secure & encrypted payments

Puccio, D.; Novo, G.; Baiamonte, V.; Nuccio, A.; Fazio, G.; Corrado, E.; Coppola, G.; Muratori, I.; Vernuccio, L.; Novo, S. 2009: Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiologica 57(2): 143-150
Jia, J-ping.; Wang, Y-hua.; Wei, C-bai. 2011: Chinese guidelines for diagnosis and management of cognitive impairment and dementia (V): dementia therapy Zhonghua Yi Xue Za Zhi 91(14): 940-945
Lechat, P.; Lardoux, H.; Mallet, A.; Sanchez, P.; Derumeaux, G.; Lecompte, T.; Maillard, L.; Mas, J.L.; Mentré, F.; Pousset, F.; Lacomblez, L.; Pisica, G.; Solbes-Latourette, S.; Raynaud, P.; Chaumet-Riffaud, P. 2000: Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. a randomized trial (FFAACS) Therapie 55(6): 681-689
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Frantz, E. 2000: What anticoagulant therapy should be used for what form of atrial fibrillation? Deutsche Medizinische Wochenschrift 125(Suppl 1): S10-S11
Strain, J.; Templeton, K. 2013: Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? South Dakota Medicine: the Journal of the South Dakota State Medical Association 66(1): 20-21
Litvinenko, I.V.; Odinak, M.M.; Mogil'naia, V.I.; Perstenev, S.V. 2008: Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(10): 37-42
Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V. 2018: Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease Kardiologiia 2018(3): 43-52
Jia, J-ping.; Wang, Y-hua.; Li, Y-sheng. 2011: Chinese guidelines for diagnosis and management of cognitive impairment and dementia (II): dementia subtypes and their criteria Zhonghua Yi Xue Za Zhi 91(10): 651-655
Wang, W.; Xie, H.; Wan, Q.; Wang, L. 2002: The cognitive variations among non-dementia elders: from successful aging to mild cognitive impairment Zhonghua Nei Ke Za Zhi 41(10): 671-674
Njamnshi, A.K.; Djientcheu, V.de.Paul.; Fonsah, J.Y.; Yepnjio, F.N.; Njamnshi, D.M.; Muna, W.E. 2008: The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon Journal of Acquired Immune Deficiency Syndromes 49(4): 393-397
Ecker-Schlipf, B. 2008: Atrial fibrillation. Pulse pressure as an important risk factor Medizinische Monatsschrift für Pharmazeuten 31(4): 153
Levada, O.A.; Traïlin, A.V. 2012: Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness Likars'ka Sprava 2012(3-4): 53-59
Yaghy, M.; Murin, J.; Pernicky, M.; Pekarovicova, Z.; Mikes, P. 2008: Antithrombotic treatment in patients with atrial fibrillation as a risk factor of stroke Bratislavske Lekarske Listy 109(3): 133-140
Lipnitskiĭ, T.N.; Dorogan, A.V.; Randin, A.G.; Kotsuta, G.I. 1992: Clinical effectiveness and potential hazards of combined kordaron and quinidine therapy of patients with atrial fibrillation Klinicheskaia Meditsina 70(3-4): 31-34
2006: Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients MMW Fortschritte der Medizin 148(23): 58-59
Xu, H.F.; He, Y.M.; Qian, Y.X.; Zhao, X.; Li, X.; Yang, X.J. 2011: Left ventricular posterior wall thickness is an independent risk factor for paroxysmal atrial fibrillation West Indian Medical Journal 60(6): 647-652
Bellomo, A.; Mancinella, M.; Troisi, G.; Marigliano, V. 2009: Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities Recenti Progressi in Medicina 100(3): 124-126
de Lepeleire, J.; Decorte, P.; Heyrman, J.; Buntinx, F. 2000: Cognitive impairment and dementia in hypertension; the effect of antihypertensive agents Nederlands Tijdschrift Voor Geneeskunde 144(42): 2033-4; author reply 2034-5
Kurz, X.; Scuvee-Moreau, J.; Vernooij-Dassen, M.; Dresse, A. 2003: Cognitive impairment, dementia and quality of life in patients and caregivers Acta Neurologica Belgica 103(1): 24-34